These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 7717367

  • 1. Idiopathic osteonecrosis, hypofibrinolysis, high plasminogen activator inhibitor, high lipoprotein(a), and therapy with Stanozolol.
    Glueck CJ, Freiberg R, Glueck HI, Tracy T, Stroop D, Wang Y.
    Am J Hematol; 1995 Apr; 48(4):213-20. PubMed ID: 7717367
    [Abstract] [Full Text] [Related]

  • 2. Hypofibrinolysis: a common, major cause of osteonecrosis.
    Glueck CJ, Freiberg R, Glueck HI, Henderson C, Welch M, Tracy T, Stroop D, Hamer T, Sosa F, Levy M.
    Am J Hematol; 1994 Feb; 45(2):156-66. PubMed ID: 8141121
    [Abstract] [Full Text] [Related]

  • 3. Familial high plasminogen activator inhibitor with hypofibrinolysis, a new pathophysiologic cause of osteonecrosis?
    Glueck CJ, Glueck HI, Mieczkowski L, Tracy T, Speirs J, Stroop D.
    Thromb Haemost; 1993 May 03; 69(5):460-5. PubMed ID: 8322268
    [Abstract] [Full Text] [Related]

  • 4. A preliminary pilot study of treatment of thrombophilia and hypofibrinolysis and amelioration of the pain of osteonecrosis of the jaws.
    Glueck CJ, McMahon RE, Bouquot JE, Tracy T, Sieve-Smith L, Wang P.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1998 Jan 03; 85(1):64-73. PubMed ID: 9474617
    [Abstract] [Full Text] [Related]

  • 5. Inheritance conjointly contributing to fibrinolysis and hyperlipidemia.
    Glueck CJ, Glueck HI, Tracy T, Speirs J, Stroop D.
    Metabolism; 1993 Nov 03; 42(11):1410-9. PubMed ID: 8231835
    [Abstract] [Full Text] [Related]

  • 6. Familial idiopathic osteonecrosis mediated by familial hypofibrinolysis with high levels of plasminogen activator inhibitor.
    Glueck CJ, Glueck HI, Welch M, Freiberg R, Tracy T, Hamer T, Stroop D.
    Thromb Haemost; 1994 Feb 03; 71(2):195-8. PubMed ID: 8191398
    [Abstract] [Full Text] [Related]

  • 7. The pathophysiology of alveolar osteonecrosis of the jaw: anticardiolipin antibodies, thrombophilia, and hypofibrinolysis.
    Gruppo R, Glueck CJ, McMahon RE, Bouquot J, Rabinovich BA, Becker A, Tracy T, Wang P.
    J Lab Clin Med; 1996 May 03; 127(5):481-8. PubMed ID: 8621985
    [Abstract] [Full Text] [Related]

  • 8. Thrombophilia and hypofibrinolysis: pathophysiologies of osteonecrosis.
    Glueck CJ, Freiberg R, Tracy T, Stroop D, Wang P.
    Clin Orthop Relat Res; 1997 Jan 03; (334):43-56. PubMed ID: 9005895
    [Abstract] [Full Text] [Related]

  • 9. [Relationship of lipoprotein(a) to fibrinolytic activities in healthy subjects].
    Xiong X, Zhao S, Wang Z, Lo L, Huang Q.
    Hunan Yi Ke Da Xue Xue Bao; 1998 Jan 03; 23(6):555-7. PubMed ID: 10806767
    [Abstract] [Full Text] [Related]

  • 10. Relationships between lipoprotein(a), lipids, apolipoproteins, basal and stimulated fibrinolytic regulators, and D-dimer.
    Glueck CJ, Glueck HI, Tracy T, Speirs J, McCray C, Stroop D.
    Metabolism; 1993 Feb 03; 42(2):236-46. PubMed ID: 8474322
    [Abstract] [Full Text] [Related]

  • 11. Effect of niceritrol on fibrinolysis and lipoprotein (a) levels in patients with coronary artery disease.
    Suefuji H, Ogawa H, Yasue H, Imoto N, Sakamoto T, Miyao Y, Kaikita K, Soejima H, Nishiyama K.
    Coron Artery Dis; 1996 Feb 03; 7(2):167-72. PubMed ID: 8813450
    [Abstract] [Full Text] [Related]

  • 12. Myocardial infarction in a 35-year-old man with homocysteinemia, high plasminogen activator inhibitor activity, and resistance to activated protein C.
    Glueck CJ, Fontaine RN, Gupta A, Alasmi M.
    Metabolism; 1997 Dec 03; 46(12):1470-2. PubMed ID: 9439545
    [Abstract] [Full Text] [Related]

  • 13. The influence of isotretinoin upon fibrinolysis in patients with acne.
    Dootson GM, Keidan J, Harper PL.
    Br J Dermatol; 1995 Jul 03; 133(1):66-70. PubMed ID: 7669643
    [Abstract] [Full Text] [Related]

  • 14. Thrombophilia, hypofibrinolysis, and alveolar osteonecrosis of the jaws.
    Glueck CJ, McMahon RE, Bouquot J, Stroop D, Tracy T, Wang P, Rabinovich B.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1996 May 03; 81(5):557-66. PubMed ID: 8734702
    [Abstract] [Full Text] [Related]

  • 15. Procoagulants and osteonecrosis.
    Jones LC, Mont MA, Le TB, Petri M, Hungerford DS, Wang P, Glueck CJ.
    J Rheumatol; 2003 Apr 03; 30(4):783-91. PubMed ID: 12672200
    [Abstract] [Full Text] [Related]

  • 16. Plasminogen activator inhibitor activity: an independent risk factor for the high miscarriage rate during pregnancy in women with polycystic ovary syndrome.
    Glueck CJ, Wang P, Fontaine RN, Sieve-Smith L, Tracy T, Moore SK.
    Metabolism; 1999 Dec 03; 48(12):1589-95. PubMed ID: 10599993
    [Abstract] [Full Text] [Related]

  • 17. Hypofibrinolysis, lipoprotein(a), and plasminogen activator inhibitor.
    Berger CE, Kröner A, Stiegler H, Erdel M, Haas OA, Engel A.
    Clin Orthop Relat Res; 2002 Apr 03; (397):342-9. PubMed ID: 11953626
    [Abstract] [Full Text] [Related]

  • 18. Disturbances in the tissue plasminogen activator/plasminogen activator inhibitor (TPA/PAI) system in systemic lupus erythematosus.
    Ruiz-Argüelles GJ, Ruiz-Argüelles A, Lobato-Mendizábal E, Díaz-Gomez F, Pacheco-Pantoja E, Drenkard C, Alarcón-Segovia D.
    Am J Hematol; 1991 May 03; 37(1):9-13. PubMed ID: 1902623
    [Abstract] [Full Text] [Related]

  • 19. Relationships between euglobulin clot lysis time and the plasma levels of tissue plasminogen activator and plasminogen activator inhibitor 1.
    Urano T, Sakakibara K, Rydzewski A, Urano S, Takada Y, Takada A.
    Thromb Haemost; 1990 Feb 19; 63(1):82-6. PubMed ID: 2111051
    [Abstract] [Full Text] [Related]

  • 20. Decreased fibrinolytic potential in patients with idiopathic avascular necrosis and transient osteoporosis of the hip.
    Van Veldhuizen PJ, Neff J, Murphey MD, Bodensteiner D, Skikne BS.
    Am J Hematol; 1993 Dec 19; 44(4):243-8. PubMed ID: 8237994
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.